IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity

被引：0
|
作者：
Khurshed, Mohammed
Aarnoudse, Niels
Hulsbos, Renske
Hira, Vashendriya V. V.
van Laarhoven, Hanneke W. M.
Wilmink, Johanna W.
Molenaar, Remco J.
van Noorden, Cornelis J.
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
250.8
引用
收藏
页数：5
相关论文
共 50 条
  • [41] ZEB1 expression is increased in IDH1-mutant lower-grade gliomas
    Cody L. Nesvick
    Chao Zhang
    Nancy A. Edwards
    Blake K. Montgomery
    Michaela Lee
    Chunzhang Yang
    Herui Wang
    Dongwang Zhu
    John D. Heiss
    Marsha J. Merrill
    Abhik Ray-Chaudhury
    Zhengping Zhuang
    Journal of Neuro-Oncology, 2016, 130 : 111 - 122
  • [42] R-2-HYDROXYGLUTARATE SHAPES THE IMMUNE MICROENVIRONMENT IN IDH1-MUTANT GLIOMAS
    Friedrich, M.
    Bunse, L.
    Bunse, T.
    Pusch, S.
    Sahm, F.
    Sanghvi, K.
    Steadman, M.
    Niemeyer, B.
    Wick, W.
    Platten, M.
    NEURO-ONCOLOGY, 2017, 19 : 20 - 21
  • [43] Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment
    Subramani, Elavarasan
    Radoul, Marina
    Najac, Chloe
    Batsios, Georgios
    Molloy, Abigail R.
    Hong, Donghyun
    Gillespie, Anne Marie
    Delos Santos, Romelyn
    Viswanath, Pavithra
    Costello, Joseph F.
    Pieper, Russell O.
    Ronen, Sabrina M.
    CANCER RESEARCH, 2020, 80 (22) : 5098 - 5108
  • [44] A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma
    Ohka, Fumiharu
    Yamamichi, Akane
    Kurimoto, Michihiro
    Motomura, Kazuya
    Tanahashi, Kuniaki
    Suzuki, Hiromichi
    Aoki, Kosuke
    Deguchi, Shoichi
    Chalise, Lushun
    Hirano, Masaki
    Kato, Akira
    Nishimura, Yusuke
    Hara, Masahito
    Kato, Yukinari
    Wakabayashi, Toshihiko
    Natsume, Atsushi
    BRAIN TUMOR PATHOLOGY, 2017, 34 (02) : 91 - 97
  • [45] A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma
    Fumiharu Ohka
    Akane Yamamichi
    Michihiro Kurimoto
    Kazuya Motomura
    Kuniaki Tanahashi
    Hiromichi Suzuki
    Kosuke Aoki
    Shoichi Deguchi
    Lushun Chalise
    Masaki Hirano
    Akira Kato
    Yusuke Nishimura
    Masahito Hara
    Yukinari Kato
    Toshihiko Wakabayashi
    Atsushi Natsume
    Brain Tumor Pathology, 2017, 34 : 91 - 97
  • [46] A genome-wide CRISPR screen identifies ARID1A as a potential resistance marker of IDH1 inhibitor in IDH1-mutant cholangiocarcinoma cell
    Kondo, Tomohiro
    Kikuchi, Osamu
    Wang, Yafeng
    Nakai, Yukie
    Ida, Tomomi
    Cao, Yang
    Vu, Trang H.
    Kondo, Yuki
    Sunami, Tomohiko
    Yamamoto, Yoshihiro
    Saito, Tomoki
    Kataoka, Shigeki
    Yamada, Atsushi
    Kanai, Masashi
    Ohashi, Shinya
    Muto, Manabu
    CANCER RESEARCH, 2024, 84 (06)
  • [47] The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas
    Natsume, Atsushi
    Arakawa, Yoshiki
    Narita, Yoshitaka
    Sugiyama, Kazuhiko
    Hata, Nobuhiro
    Muragaki, Yoshihiro
    Shinojima, Naoki
    Kumabe, Toshihiro
    Saito, Ryuta
    Motomura, Kazuya
    Mineharu, Yohei
    Miyakita, Yasuji
    Yamasaki, Fumiyuki
    Matsushita, Yuko
    Ichimura, Koichi
    Ito, Kazumi
    Tachibana, Masaya
    Kakurai, Yasuyuki
    Okamoto, Naoko
    Asahi, Takashi
    Nishijima, Soichiro
    Yamaguchi, Tomoyuki
    Tsubouchi, Hiroshi
    Nakamura, Hideo
    Nishikawa, Ryo
    NEURO-ONCOLOGY, 2023, 25 (02) : 326 - 336
  • [48] Analysis of tumor and microenvironment in IDH1-mutant gliomas using single cell transcriptome analysis
    Venteicher, Andrew
    Tirosh, Itay
    Hebert, Christine
    Escalante, Leah
    Martuza, Robert
    Nahed, Brian
    Curry, William
    Cahill, Daniel
    Bernstein, Bradley
    Louis, David
    Regev, Aviv
    Suva, Mario
    JOURNAL OF NEUROSURGERY, 2017, 126 (04) : A1429 - A1429
  • [49] R-2-HG assists IDH1-mutant solid tumors by promoting angiogenesis
    Bogurcu-Seidel, Nuray
    Bergers, Gabriele
    CELL RESEARCH, 2022, 32 (09) : 795 - 796
  • [50] A BIOBANK OF IDH1-MUTANT CELL LINES FOR STUDYING TUMOR HETEROGENEITY, PROGRESSION AND TARGET IDENTIFICATION
    Garcia, L.
    Pineau, D.
    Hideg, S.
    Rigau, V.
    Darlix, A.
    Bauchet, L.
    Duffau, H.
    Hugnot, J.
    NEURO-ONCOLOGY, 2023, 25
12345